Effectiveness and Safety of Firmagon®

Clinical trial NCT00930319 · COMPLETED

Trial details

NCT number: NCT00930319
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma

Start date: 2009-06-01
Primary completion: 2013-12-01
Enrollment: 676

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.